Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

KRAS G12D inhibitor 22

KRAS G12D inhibitor 22 (compound 6) is a KRAS mutation inhibitor with high antitumor activity (IC50 < 100 nM), excellent selectivity, and low toxicity. It is applicable in breast cancer research.

Product Specifications

Field of Research

Pharmacology & Drug Discovery, Signal Transduction

Storage Conditions

-20°C

Notes

For research use only.

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

TYRP1 (Tyrosinase Related Protein 1) (TA99), CF405S conjugate, 0.1mg/mL
BNC040806-100 1x 100 µL

TYRP1 (Tyrosinase Related Protein 1) (TA99), CF405S conjugate, 0.1mg/mL

Sign In for Pricing
View Details
MMP9 (rMMP9/1769), CF647 conjugate, 0.1mg/mL
BNC472176-100 1x 100 µL

MMP9 (rMMP9/1769), CF647 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD9 (TSPAN29) (Motility-Related Protein-1) (CD9/2343), CF740 conjugate, 0.1mg/mL
BNC742343-100 1x 100 µL

CD9 (TSPAN29) (Motility-Related Protein-1) (CD9/2343), CF740 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
Cytokeratin 14 (LL002), CF405S conjugate, 0.1mg/mL
BNC040499-500 1x 500 µL

Cytokeratin 14 (LL002), CF405S conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD31 / PECAM-1 (JC/70A), CF740 conjugate, 0.1mg/mL
BNC740639-500 1x 500 µL

CD31 / PECAM-1 (JC/70A), CF740 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
P53 (BP53-12), CF405S conjugate, 0.1mg/mL
BNC040013-500 1x 500 µL

P53 (BP53-12), CF405S conjugate, 0.1mg/mL

Sign In for Pricing
View Details